Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

EMBL Ventures

Investor type Micro VC
Founders Jan Adams Stefan Herr


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 19
Average round size
The average size of a deal this fund participated in
Portfolio companies 13
Rounds per year 0.95
Lead investments 4
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 6
Key employees 5
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical

The leading representative office of defined VC is situated in the Heidelberg. The venture was found in Europe in Germany.

Speaking about the real fund results, this VC is 11 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this EMBL Ventures performs on 4 percentage points less the average number of lead investments. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2013. The increased amount of exits for fund were in 2017. Deals in the range of 10 - 50 millions dollars are the general things for fund.

We also calculated 5 valuable employees in our database.

Among the most popular fund investment industries, there are Biopharma, Medical. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the location of its establishment and the land of its numerous investments - Germany. Among the most popular portfolio startups of the fund, we may highlight Vasopharm, Opsona, Crescendo Biologics.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the EMBL Ventures, startups are often financed by Sofinnova Partners, Seroba Life Sciences, Inventages Venture Capital Investment Inc.. The meaningful sponsors for the fund in investment in the same round are Andera Partners, Wellington Partners, Sunstone Life Science Ventures. In the next rounds fund is usually obtained by Wellington Partners, dievini Hopp Biotech Holding, Entrepreneurs Fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of EMBL Ventures:
Typical Co-investors
EMBL Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after EMBL Ventures:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Germany
Funds with similar focus located in Germany:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
B-Style Japan, Yamanashi, Yamanashi Prefecture
Blockchange Ventures New York, New York, United States
CFV Ventures Charlotte, North Carolina, United States
Dalma Capital Dubai, United Arab Emirates
Estiriac SL -
Gernot Langes-Swarovski Group -
Headway Capital Partners England, London, United Kingdom
Memorial Hermann Hospital Houston, Texas, United States
Myer Family Investments Australia, Melbourne, Victoria
NewSpring Capital Pennsylvania, Radnor, United States
Ningbo Gaofa Automotive Control System China, Ningbo Shi, Zhejiang
One Media Hokkaido Prefecture, Japan, Meguro
Pine Brook Partners New York, New York, United States
Tenfore Holdings New York, New York, United States
TQS Advisors -
VCO Ventures Germany, Hamburg
Wanrong Capital Beijing, Beijing, China
Weigao Group China, Shandong, Weihai
Yunfeng Touzi China, Hangzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Topas Therapeutics

Advanced Materials
Chemical Engineering
$21M29 Jul 2021 Germany, Baden-Württemberg, Germany

Topas Therapeutics

Advanced Materials
Chemical Engineering
$25M19 Oct 2020 Germany, Baden-Württemberg

Crescendo Biologics

Health Care
$70M30 Apr 2018 Cambridge, England, United Kingdom


Health Care
Life Science
$45M26 Apr 2017 Vienna


$9M12 Jan 2017 Baden-Württemberg

Allecra Therapeutics

$25M15 Jun 2016 Baden-Württemberg

Topas Therapeutics

Advanced Materials
Chemical Engineering
$16M22 Mar 2016 Germany, Baden-Württemberg, Germany


$7M14 Oct 2015 Heidelberg, Baden-Württemberg, Germany

Vira Therapeutics

Health Care
$4M24 Jun 2015 Innsbruck, Tyrol, Austria


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent EMBL Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: